FDA NAMs-Aligned
Predictive Toxicology
AI-Driven Analytics
Human-Centric Models
Digital Organ Twins
Quantum-Enhanced Modeling
Patented Technology
Precision Disease Models
Reduced Animal Testing
FDA NAMs-Aligned
Predictive Toxicology
AI-Driven Analytics
Human-Centric Models
Digital Organ Twins
Quantum-Enhanced Modeling
Patented Technology
Precision Disease Models
Reduced Animal Testing
Dr. Prabodh brings a unique multidisciplinary background that drives convergence of artificial intelligence, quantum computing, and bioengineering to transform drug discovery. He holds a PhD in Mechanical Engineering and an MBA from New York University.
Professor Panindre, the Inaugural Director of the startAD entrepreneurship accelerator at NYUAD, has authored patents and publications in the field of AI and quantum technologies, and has received an NSF grant to translate cutting-edge AI research into a scalable, high-impact venture.